Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

Enadenotucirev is an oncolytic group B adenovirus identified by a process of bio-selection for the ability to selectively propagate in and rapidly kill carcinoma cells. It is resistant to inactivation by human blood components, potentially enabling intravenous dosing in patients with metastatic canc...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Sam Illingworth, Ying Di, Maxine Bauzon, Janet Lei, Margaret R. Duffy, Simon Alvis, Brian Champion, André Lieber, Terry Hermiston, Len W. Seymour, John Beadle, Kerry Fisher
स्वरूप: लेख
भाषा:English
प्रकाशित: Elsevier 2017-06-01
श्रृंखला:Molecular Therapy: Oncolytics
विषय:
enadenotucirev
adenovirus
oncolytic virotherapy
preclinical model
mouse model
ऑनलाइन पहुंच:http://www.sciencedirect.com/science/article/pii/S2372770517300177

इंटरनेट

http://www.sciencedirect.com/science/article/pii/S2372770517300177

समान संसाधन